1534 related articles for article (PubMed ID: 6206157)
1. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
2. Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes.
Glorioso J; Kees U; Kümel G; Kirchner H; Krammer PH
J Immunol; 1985 Jul; 135(1):575-82. PubMed ID: 2582051
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C
J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135
[TBL] [Abstract][Full Text] [Related]
4. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity.
Paya CV; McKean DJ; Segal DM; Schoon RA; Showalter SD; Leibson PJ
J Immunol; 1989 Jan; 142(2):666-71. PubMed ID: 2536060
[TBL] [Abstract][Full Text] [Related]
5. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
Colmenares C; Lopez C
J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
[TBL] [Abstract][Full Text] [Related]
6. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. III. Analysis of viral glycoproteins recognized by CTL clones by using recombinant herpes simplex viruses.
Yasukawa M; Zarling JM
J Immunol; 1985 Apr; 134(4):2679-82. PubMed ID: 2579149
[TBL] [Abstract][Full Text] [Related]
7. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing.
Perl A; Looney RJ; Ryan DH; Abraham GN
J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902
[TBL] [Abstract][Full Text] [Related]
8. Alterations in the antigenic structure of two major HSV-1 glycoproteins, gC and gB, influence immune regulation and susceptibility to murine herpes keratitis.
Hendricks RL; Tao MS; Glorioso JC
J Immunol; 1989 Jan; 142(1):263-9. PubMed ID: 2909617
[TBL] [Abstract][Full Text] [Related]
9. Specific effect of anti-transferrin antibodies on natural killer cells directed against tumor cells. Evidence for the transferrin receptor being one of the target structures recognized by NK cells.
Alarcón B; Fresno M
J Immunol; 1985 Feb; 134(2):1286-91. PubMed ID: 2981268
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of recognition of herpes simplex virus type 1-infected cells by natural killer cells.
López-Guerrero JA; Alarcón B; Fresno M
J Gen Virol; 1988 Nov; 69 ( Pt 11)():2859-68. PubMed ID: 2846762
[TBL] [Abstract][Full Text] [Related]
11. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
Ritchie MH; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
[TBL] [Abstract][Full Text] [Related]
12. Use of monoclonal antibodies to HSV-1 and HSV-2 for serological analysis of the viral glycoproteins.
Pereira L
Dev Biol Stand; 1982; 52():115-31. PubMed ID: 6299824
[TBL] [Abstract][Full Text] [Related]
13. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD.
Zarling JM; Moran PA; Burke RL; Pachl C; Berman PW; Lasky LA
J Immunol; 1986 Jun; 136(12):4669-73. PubMed ID: 2423598
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cells lyse autologous herpes simplex virus infected targets using cytolytic mechanisms distributed clonotypically.
Pietra G; Semino C; Cagnoni F; Boni L; Cangemi G; Frumento G; Melioli G
J Med Virol; 2000 Nov; 62(3):354-63. PubMed ID: 11055246
[TBL] [Abstract][Full Text] [Related]
15. Role of interferon in human natural killer activity against target cells infected with HSV-1.
Bishop GA; Glorioso JC; Schwartz SA
J Immunol; 1983 Oct; 131(4):1849-53. PubMed ID: 6194217
[TBL] [Abstract][Full Text] [Related]
16. Natural killer (NK)-like cytotoxic activity of allospecific T cell receptor-gamma,delta+ T cell clones. Distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity.
Koide J; Rivas A; Engleman EG
J Immunol; 1989 Jun; 142(12):4161-8. PubMed ID: 2470816
[TBL] [Abstract][Full Text] [Related]
17. Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity.
Bishop GA; Glorioso JC; Schwartz SA
J Exp Med; 1983 May; 157(5):1544-61. PubMed ID: 6189940
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of glycosylation of herpes simplex virus glycoproteins: identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane.
Glorioso J; Szczesiul MS; Marlin SD; Levine M
Virology; 1983 Apr; 126(1):1-18. PubMed ID: 6189286
[TBL] [Abstract][Full Text] [Related]
19. Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji.
Fitzgerald-Bocarsly P; Feldman M; Curl S; Schnell J; Denny T
J Immunol; 1989 Aug; 143(4):1318-26. PubMed ID: 2526183
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
Bystrická M; Petríková M; Zatovicová M; Soláriková L; Kostolanský F; Mucha V; Russ G
Acta Virol; 1997 Feb; 41(1):5-12. PubMed ID: 9199708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
